September 25, 2025International Journal of Molecular SciencesOpen Access

Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial

View Full Paper

Ask AI

Bookmark

Authors

MYMetha YaikwawongSiriraj Hospital KKKhanittha KamdeeSiriraj Hospital SCSomlak ChuengsamarnSrinakharinwirot University

Discussion

Member takes

Implication

Randomized controlled trial shows curcumin reduces liver fat and inflammation in patients with type 2 diabetes, highlighting its therapeutic potential.

Key Points

Curcumin significantly reduced liver fat content in obese patients with type 2 diabetes.
Patients receiving curcumin showed decreased glycated hemoglobin and improved antioxidant levels.
The trial monitored 227 participants for 12 months with no clinically significant adverse effects reported.
These findings emphasize curcumin’s role as a safe adjunct therapy for liver steatosis.

Cite This Study

Yaikwawong et al. (2025) studied this question.

synapsesocial.com/papers/68d5d0feddad3c16d4635f4e https://doi.org/10.3390/ijms26199286

View Full Paper

Ask AI

Bookmark

Implication

Randomized controlled trial shows curcumin reduces liver fat and inflammation in patients with type 2 diabetes, highlighting its therapeutic potential.

Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider